Mural Oncology plc (MURA)
NASDAQ: MURA · Real-Time Price · USD
2.650
+0.120 (4.74%)
At close: May 16, 2025, 4:00 PM
2.630
-0.020 (-0.75%)
After-hours: May 16, 2025, 6:45 PM EDT
Mural Oncology Stock Forecast
Stock Price Forecast
According to 3 professional analysts, the 12-month price target for Mural Oncology stock ranges from a low of $6.00 to a high of $18. The average analyst price target of $13 forecasts a 390.57% increase in the stock price over the next year.
Price Target: $13.00 (+390.57%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 26, 2025.
Analyst Ratings
The average analyst rating for Mural Oncology stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 4 | 4 | 3 | 3 | 3 |
Buy | 1 | 1 | 1 | 1 | 1 | 0 |
Hold | 0 | 0 | 0 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 5 | 5 | 5 | 5 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $18 → $6 | Strong Buy | Maintains | $18 → $6 | +126.42% | Mar 26, 2025 |
Jones Trading | Jones Trading | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 25, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +579.25% | Mar 12, 2025 |
Jones Trading | Jones Trading | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | +503.77% | Jan 27, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +579.25% | Nov 14, 2024 |
Financial Forecast
Revenue This Year
49.91M
from 37.15M
Increased by 34.35%
Revenue Next Year
n/a
from 49.91M
EPS This Year
-5.45
from -7.58
EPS Next Year
-2.34
from -5.45
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | n/a | n/a | 43.4M | ||
Avg | n/a | n/a | 20.3M | ||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -3.55 | -0.20 | -0.19 | ||
Avg | -5.45 | -2.34 | -1.96 | ||
Low | -7.10 | -3.25 | -3.34 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.